AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America.
Pathology/Histotechnology Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America.
PLoS Pathog. 2018 Jul 12;14(7):e1007130. doi: 10.1371/journal.ppat.1007130. eCollection 2018 Jul.
Human gammaherpesviruses are associated with malignancies in HIV infected individuals; in macaques used in non-human primate models of HIV infection, gammaherpesvirus infections also occur. Limited data on prevalence and tumorigenicity of macaque gammaherpesviruses, mostly cross-sectional analyses of small series, are available. We comprehensively examine all three-rhesus macaque gammaherpesviruses -Rhesus rhadinovirus (RRV), Rhesus Lymphocryptovirus (RLCV) and Retroperitoneal Fibromatosis Herpesvirus (RFHV) in macaques experimentally infected with Simian Immunodeficiency Virus or Simian Human Immunodeficiency Virus (SIV/SHIV) in studies spanning 15 years at the AIDS and Cancer Virus Program of the Frederick National Laboratory for Cancer Research. We evaluated 18 animals with malignancies (16 lymphomas, one fibrosarcoma and one carcinoma) and 32 controls. We developed real time quantitative PCR assays for each gammaherpesvirus DNA viral load (VL) in malignant and non-tumor tissues; we also characterized the tumors using immunohistochemistry and in situ hybridization. Furthermore, we retrospectively quantified gammaherpesvirus DNA VL and SIV/SHIV RNA VL in longitudinally-collected PBMCs and plasma, respectively. One or more gammaherpesviruses were detected in 17 tumors; generally, one was predominant, and the relevant DNA VL in the tumor was very high compared to surrounding tissues. RLCV was predominant in tumors resembling diffuse large B cell lymphomas; in a Burkitt-like lymphoma, RRV was predominant; and in the fibrosarcoma, RFHV was predominant. Median RRV and RLCV PBMC DNA VL were significantly higher in cases than controls; SIV/SHIV VL and RLCV VL were independently associated with cancer. Local regressions showed that longitudinal VL patterns in cases and controls, from SIV infection to necropsy, differed for each gammaherpesvirus: while RFHV VL increased only slightly in all animals, RLCV and RRV VL increased significantly and continued to increase steeply in cases; in controls, VL flattened. In conclusion, the data suggest that gammaherpesviruses may play a significant role in tumorogenesis in macaques infected with immunodeficiency viruses.
人类疱疹病毒与 HIV 感染者的恶性肿瘤有关;在用于 HIV 感染的非人灵长类动物模型的猕猴中,也会发生疱疹病毒感染。关于猕猴疱疹病毒的流行率和致瘤性,只有有限的数据,主要是小系列的横断面分析。我们在艾滋病和癌症病毒计划的弗雷德里克国家癌症研究实验室对 15 年来用猴免疫缺陷病毒或猴人免疫缺陷病毒(SIV/SHIV)感染的猕猴进行了全面研究,共检测了三种猕猴疱疹病毒 - 恒河猴疱疹病毒(RRV)、恒河猴淋巴组织增生性病毒(RLCV)和后腹膜纤维瘤疱疹病毒(RFHV)。我们评估了 18 只患有恶性肿瘤的动物(16 只淋巴瘤、1 只纤维肉瘤和 1 只癌)和 32 只对照动物。我们为每一种疱疹病毒 DNA 病毒载量(VL)在恶性和非肿瘤组织中开发了实时定量 PCR 检测方法;我们还使用免疫组织化学和原位杂交技术对肿瘤进行了特征描述。此外,我们回顾性地定量了纵向收集的 PBMCs 和血浆中的疱疹病毒 DNA VL 和 SIV/SHIV RNA VL。在 17 个肿瘤中检测到一种或多种疱疹病毒;通常,一种是主要的,并且肿瘤中的相关 DNA VL 与周围组织相比非常高。RLCV 在类似于弥漫性大 B 细胞淋巴瘤的肿瘤中占优势;在伯基特样淋巴瘤中,RRV 占优势;在纤维肉瘤中,RFHV 占优势。与对照组相比,病例组的 RRV 和 RLCV PBMC DNA VL 中位数明显较高;SIV/SHIV VL 和 RLCV VL 与癌症独立相关。局部回归显示,从 SIV 感染到尸检,病例和对照组的每种疱疹病毒的纵向 VL 模式都不同:虽然所有动物的 RFHV VL 仅略有增加,但 RLCV 和 RRV VL 显著增加,并在病例中继续急剧增加;在对照组中,VL 趋于平稳。总之,这些数据表明,疱疹病毒可能在感染免疫缺陷病毒的猕猴肿瘤发生中发挥重要作用。